{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:13:01Z","timestamp":1783357981861,"version":"3.54.6"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K05991"],"award-info":[{"award-number":["22K05991"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-05103-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:06:44Z","timestamp":1762780004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PRC1, CDCA3, and CDC20 are upregulated and Treg numbers are decreased in canine massive hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Toshiyuki","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Motegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Iimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Akiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"5103_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/030098588101800402","volume":"18","author":"AK Patnaik","year":"1981","unstructured":"Patnaik AK, Hurvitz AI, Lieberman PH, Johnson GF. Canine hepatocellular carcinoma. Vet Pathol. 1981;18:427\u201338. https:\/\/doi.org\/10.1177\/030098588101800402.","journal-title":"Vet Pathol"},{"key":"5103_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tvjl.2013.05.027","volume":"197","author":"MRGH van Sprundel","year":"2013","unstructured":"van Sprundel MRGH, van den Ingh M, Guscetti TSGA, Kershaw F, Kanemoto O, van Gils HM. Classification of primary hepatic tumours in the dog. Vet J. 2013;197:596\u2013606. https:\/\/doi.org\/10.1016\/j.tvjl.2013.05.027.","journal-title":"Vet J"},{"key":"5103_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2460\/javma.2004.225.1225","volume":"225","author":"JM Liptak","year":"2004","unstructured":"Liptak JM, Dernell WS, Monnet E, Powers BE, Bachand AM, Kenney JG, et al. Massive hepatocellular carcinoma in dogs: 48 cases (1992\u20132002). J Am Vet Med Assoc. 2004;225:1225\u201330. https:\/\/doi.org\/10.2460\/javma.2004.225.1225.","journal-title":"J Am Vet Med Assoc"},{"key":"5103_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/00480169.2017.1319304","volume":"65","author":"A Matsuyama","year":"2017","unstructured":"Matsuyama A, Takagi S, Hosoya K, Kagawa Y, Nakamura K, Deguchi T, et al. Impact of surgical margins on survival of 37 dogs with massive hepatocellular carcinoma. N Z Vet J. 2017;65:227\u201331. https:\/\/doi.org\/10.1080\/00480169.2017.1319304.","journal-title":"N Z Vet J"},{"key":"5103_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/vco.12824","volume":"20","author":"JM Lapsley","year":"2022","unstructured":"Lapsley JM, Wavreille V, Barry S, Dornbusch JA, Chen C, Leeper H, et al. Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: a veterinary society of surgical oncology case-control study. Vet Comp Oncol. 2022;20:697\u2013709. https:\/\/doi.org\/10.1111\/vco.12824.","journal-title":"Vet Comp Oncol"},{"key":"5103_CR6","doi-asserted-by":"crossref","unstructured":"Liptak J. Cancer of the Gastrointestinal tract. In: Vail D, Thamm D, Liptak J, editors. Withrow and MacEwen\u2019s Small Animal Clinical Oncology. 6th ed. St. Louis, MO:W.B. Saunders; 2020. pp. 432\u201391.","DOI":"10.1016\/B978-0-323-59496-7.00023-2"},{"key":"5103_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/genes13122331","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Li J, He T, Song Y, Wu J, Wang B. Significance of identifying key genes involved in HBV-related hepatocellular carcinoma for primary care surveillance of patients with cirrhosis. Genes. 2022;13:2331. https:\/\/doi.org\/10.3390\/genes13122331.","journal-title":"Genes"},{"key":"5103_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030568","volume":"14","author":"H Takeda","year":"2022","unstructured":"Takeda H, Takai A, Eso Y, Takahashi K, Marusawa H, Seno H. Genetic landscape of multistep hepatocarcinogenesis. Cancers (Basel). 2022;14:568. https:\/\/doi.org\/10.3390\/cancers14030568.","journal-title":"Cancers (Basel)"},{"key":"5103_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/hep4.1564","volume":"4","author":"G Brar","year":"2020","unstructured":"Brar G, Greten TF, Graubard BI, McNeel TS, Petrick JL, McGlynn KA, et al. Hepatocellular carcinoma survival by etiology: a SEER-medicare database analysis. Hepatol Commun. 2020;4:1541\u201351. https:\/\/doi.org\/10.1002\/hep4.1564.","journal-title":"Hepatol Commun"},{"key":"5103_CR10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1245\/s10434-020-08452-3","volume":"27","author":"DI Tsilimigras","year":"2020","unstructured":"Tsilimigras DI, Bagante F, Moris D, Hyer JM, Sahara K, Paredes AZ, et al. Recurrence patterns and outcomes after resection of hepatocellular carcinoma within and beyond the Barcelona clinic liver cancer criteria. Ann Surg Oncol. 2020;27:2321\u201331. https:\/\/doi.org\/10.1245\/s10434-020-08452-3.","journal-title":"Ann Surg Oncol"},{"key":"5103_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","volume":"243","author":"N Portolani","year":"2006","unstructured":"Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GAM, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229\u201335. https:\/\/doi.org\/10.1097\/01.sla.0000197706.21803.a1.","journal-title":"Ann Surg"},{"key":"5103_CR12","doi-asserted-by":"publisher","first-page":"934883","DOI":"10.3389\/fgene.2022.934883","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Wang Y, Hu M, Lu X, Sun G. Identification of oncogenes and tumor-suppressor genes with hepatocellular carcinoma: A comprehensive analysis based on TCGA and GEO datasets. Front Genet. 2022;13:934883. https:\/\/doi.org\/10.3389\/fgene.2022.934883.","journal-title":"Front Genet"},{"key":"5103_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jhep.2009.12.034","volume":"52","author":"L Zender","year":"2010","unstructured":"Zender L, Villanueva A, Tovar V, Sia D, Chiang DY, Llovet JM. Cancer gene discovery in hepatocellular carcinoma. J Hepatol. 2010;52:921\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2009.12.034.","journal-title":"J Hepatol"},{"key":"5103_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2006-960171","volume":"27","author":"A Villanueva","year":"2007","unstructured":"Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis. 2007;27:55\u201376. https:\/\/doi.org\/10.1055\/s-2006-960171.","journal-title":"Semin Liver Dis"},{"key":"5103_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","volume":"149","author":"J Zucman-Rossi","year":"2015","unstructured":"Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149:1226\u2013e12394. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.061.","journal-title":"Gastroenterology"},{"key":"5103_CR16","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","volume":"132","author":"J Fu","year":"2007","unstructured":"Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology. 2007;132:2328\u201339. https:\/\/doi.org\/10.1053\/j.gastro.2007.03.102.","journal-title":"Gastroenterology"},{"key":"5103_CR17","first-page":"148","volume":"68","author":"HJ Choi","year":"2018","unstructured":"Choi HJ, Lee HB, Park HK, Cho SM, Han HJ, Lee SJ, et al. EZH2 expression in naturally occurring canine tumors. Comp Med. 2018;68:148\u201355.","journal-title":"Comp Med"},{"key":"5103_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1292\/jvms.13-0378","volume":"76","author":"G Iida","year":"2014","unstructured":"Iida G, Asano K, Seki M, Sakai M, Kutara K, Ishigaki K, et al. Gene expression of growth factors and growth factor receptors for potential targeted therapy of canine hepatocellular carcinoma. J Vet Med Sci. 2014;76:301\u20136. https:\/\/doi.org\/10.1292\/jvms.13-0378.","journal-title":"J Vet Med Sci"},{"key":"5103_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-024-07016-y","volume":"17","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Motegi T, Mori M, Sumikawa N, Maeda K, Iimori Y, et al. Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy. BMC Res Notes. 2024;17:357. https:\/\/doi.org\/10.1186\/s13104-024-07016-y.","journal-title":"BMC Res Notes"},{"key":"5103_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"key":"5103_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323. https:\/\/doi.org\/10.1186\/1471-2105-12-323.","journal-title":"BMC Bioinformatics"},{"key":"5103_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"5103_CR23","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","volume":"35","author":"G Sturm","year":"2019","unstructured":"Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436\u201345. https:\/\/doi.org\/10.1093\/bioinformatics\/btz363.","journal-title":"Bioinformatics"},{"key":"5103_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0555-4","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Li Y, Meng L, Liu XY, Peng A, Chen Y, et al. Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma. Cell Death Dis. 2018;9:534. https:\/\/doi.org\/10.1038\/s41419-018-0555-4.","journal-title":"Cell Death Dis"},{"key":"5103_CR25","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.febslet.2005.01.055","volume":"579","author":"K Yoshida","year":"2005","unstructured":"Yoshida K. Cell-cycle-dependent regulation of the human and mouse Tome-1 promoters. FEBS Lett. 2005;579:1488\u201392. https:\/\/doi.org\/10.1016\/j.febslet.2005.01.055.","journal-title":"FEBS Lett"},{"key":"5103_CR26","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/sj.onc.1210799","volume":"27","author":"T Kidokoro","year":"2008","unstructured":"Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K. CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene. 2008;27:1562\u201371. https:\/\/doi.org\/10.1038\/sj.onc.1210799.","journal-title":"Oncogene"},{"key":"5103_CR27","doi-asserted-by":"publisher","first-page":"12131","DOI":"10.1073\/pnas.2001760117","volume":"117","author":"CF Nielsen","year":"2020","unstructured":"Nielsen CF, Zhang T, Barisic M, Kalitsis P, Hudson DF. Topoisomerase II\u03b1 is essential for maintenance of mitotic chromosome structure. Proc Natl Acad Sci U S A. 2020;117:12131\u201342. https:\/\/doi.org\/10.1073\/pnas.2001760117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5103_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70949","volume":"14","author":"Z Wan","year":"2025","unstructured":"Wan Z, Wen M, Zheng C, Sun Y, Zhou Y, Tian Y, et al. Centromere protein f in tumor biology: cancer\u2019s Achilles heel. Cancer Med. 2025;14:e70949. https:\/\/doi.org\/10.1002\/cam4.70949.","journal-title":"Cancer Med"},{"key":"5103_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061600","volume":"12","author":"NM Tuan","year":"2020","unstructured":"Tuan NM, Lee CH. Role of anillin in tumour: from a prognostic biomarker to a novel target. Cancers (Basel). 2020;12:1600. https:\/\/doi.org\/10.3390\/cancers12061600.","journal-title":"Cancers (Basel)"},{"key":"5103_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1387\/ijdb.130047av","volume":"57","author":"DJ Wolgemuth","year":"2013","unstructured":"Wolgemuth DJ, Manterola M, Vasileva A. Role of cyclins in controlling progression of mammalian spermatogenesis. Int J Dev Biol. 2013;57:159\u201368. https:\/\/doi.org\/10.1387\/ijdb.130047av.","journal-title":"Int J Dev Biol"},{"key":"5103_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/gen-2024-0111","volume":"68","author":"MC Burns","year":"2025","unstructured":"Burns MC, Borgal L. Asp\/ASPM phospho-regulation throughout the cell cycle. Genome. 2025;68:1\u201310. https:\/\/doi.org\/10.1139\/gen-2024-0111.","journal-title":"Genome"},{"key":"5103_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06746-2","volume":"23","author":"S Xu","year":"2025","unstructured":"Xu S, Nan D, Liu R, Liu C, Hu Y, Huang L, et al. The role and therapeutic value of NUSAP1 in human cancers. J Transl Med. 2025;23:725. https:\/\/doi.org\/10.1186\/s12967-025-06746-2.","journal-title":"J Transl Med"},{"key":"5103_CR33","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s00018-014-1582-7","volume":"71","author":"G Neumayer","year":"2014","unstructured":"Neumayer G, Belzil C, Gruss OJ, Nguyen MD. TPX2: of spindle assembly, DNA damage response, and cancer. Cell Mol Life Sci. 2014;71:3027\u201347. https:\/\/doi.org\/10.1007\/s00018-014-1582-7.","journal-title":"Cell Mol Life Sci"},{"key":"5103_CR34","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1091\/mbc.e03-02-0108","volume":"14","author":"AJ Faragher","year":"2003","unstructured":"Faragher AJ, Fry AM. Nek2A kinase stimulates centrosome disjunction and is required for formation of bipolar mitotic spindles. Mol Biol Cell. 2003;14:2876\u201389. https:\/\/doi.org\/10.1091\/mbc.e03-02-0108.","journal-title":"Mol Biol Cell"},{"key":"5103_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02136-8","volume":"4","author":"K Kildey","year":"2021","unstructured":"Kildey K, Gandhi NS, Sahin KB, Shah ET, Boittier E, Duijf PHG, et al. Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy. Commun Biol. 2021;4:638. https:\/\/doi.org\/10.1038\/s42003-021-02136-8.","journal-title":"Commun Biol"},{"key":"5103_CR36","doi-asserted-by":"publisher","first-page":"9555","DOI":"10.2147\/IJGM.S338500","volume":"14","author":"J Huang","year":"2021","unstructured":"Huang J, Zhan Y, Jiang L, Gao Y, Zhao B, Zhang Y, et al. Identification of the potential prognosis biomarkers in hepatocellular carcinoma: an analysis based on WGCNA and PPI. Int J Gen Med. 2021;14:9555\u201365. https:\/\/doi.org\/10.2147\/IJGM.S338500.","journal-title":"Int J Gen Med"},{"key":"5103_CR37","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1136\/gutjnl-2015-310625","volume":"65","author":"J Chen","year":"2016","unstructured":"Chen J, Rajasekaran M, Xia H, Zhang X, Kong SN, Sekar K, et al. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt\/\u03b2-catenin signalling pathway. Gut. 2016;65:1522\u201334. https:\/\/doi.org\/10.1136\/gutjnl-2015-310625.","journal-title":"Gut"},{"key":"5103_CR38","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/liv.15225","volume":"42","author":"Y Wang","year":"2022","unstructured":"Wang Y, Liu Y, Zhang T, Guan G, Mao T, Liu H, et al. Lnccdca3l inhibits cell proliferation via a novel RNA structure-based crosstalk with CDCA3 in hepatocellular carcinoma. Liver Int. 2022;42:1432\u201346. https:\/\/doi.org\/10.1111\/liv.15225.","journal-title":"Liver Int"},{"key":"5103_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4161\/cc.1.4.132","volume":"1","author":"CH Spruck","year":"2002","unstructured":"Spruck CH, Strohmaier HM. Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control. Cell Cycle. 2002;1:250\u20134.","journal-title":"Cell Cycle"},{"key":"5103_CR40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.7150\/jca.17640","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shi F, Xing GH, Xie P, Zhao N, Yin YF, et al. Protein regulator of cytokinesis PRC1 confers chemoresistance and predicts an unfavorable postoperative survival of hepatocellular carcinoma patients. J Cancer. 2017;8:801\u20138. https:\/\/doi.org\/10.7150\/jca.17640.","journal-title":"J Cancer"},{"key":"5103_CR41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/s1097-2765(00)80302-0","volume":"2","author":"W Jiang","year":"1998","unstructured":"Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T, et al. PRC1: A human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell. 1998;2:877\u201385. https:\/\/doi.org\/10.1016\/s1097-2765(00)80302-0.","journal-title":"Mol Cell"},{"key":"5103_CR42","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.7150\/jca.53708","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Xia L, Wang S, Cai X, Wu X, Zou C, et al. E2F4 promotes the proliferation of hepatocellular carcinoma cells through upregulation of CDCA3. J Cancer. 2021;12:5173\u201380. https:\/\/doi.org\/10.7150\/jca.53708.","journal-title":"J Cancer"},{"key":"5103_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2020.10.011","volume":"496","author":"M Shi","year":"2021","unstructured":"Shi M, Dai WQ, Jia RR, Zhang QH, Wei J, Wang YG, et al. APCCDC20-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett. 2021;496:144\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.011.","journal-title":"Cancer Lett"},{"key":"5103_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.864051","volume":"10","author":"S Liao","year":"2022","unstructured":"Liao S, Wang K, Zhang L, Shi G, Wang Z, Chen Z, et al. PRC1 and RACGAP1 are diagnostic biomarkers of early HCC and PRC1 drives self-renewal of liver cancer stem cells. Front Cell Dev Biol. 2022;10:864051. https:\/\/doi.org\/10.3389\/fcell.2022.864051.","journal-title":"Front Cell Dev Biol"},{"key":"5103_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6622437","volume":"2021","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen S, Wang G, Li S, Qin X. CDCA3 is a novel prognostic biomarker associated with immune infiltration in hepatocellular carcinoma. BioMed Res Int. 2021;2021:6622437. https:\/\/doi.org\/10.1155\/2021\/6622437.","journal-title":"BioMed Res Int"},{"key":"5103_CR46","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s10637-021-01126-1","volume":"39","author":"C Xiong","year":"2021","unstructured":"Xiong C, Wang Z, Wang G, Zhang C, Jin S, Jiang G, et al. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma. Invest New Drugs. 2021;39:1439\u201353. https:\/\/doi.org\/10.1007\/s10637-021-01126-1.","journal-title":"Invest New Drugs"},{"key":"5103_CR47","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12122","volume":"24","author":"G Yang","year":"2021","unstructured":"Yang G, Wang G, Xiong Y, Sun J, Li W, Tang T, et al. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition. Mol Med Rep. 2021;24:483. https:\/\/doi.org\/10.3892\/mmr.2021.12122.","journal-title":"Mol Med Rep"},{"key":"5103_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057\u201361. https:\/\/doi.org\/10.1126\/science.1079490.","journal-title":"Science"},{"key":"5103_CR49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.canlet.2019.05.003","volume":"457","author":"R Saleh","year":"2019","unstructured":"Saleh R, Elkord E. Treg-mediated acquired resistance to immune checkpoint inhibitors. Cancer Lett. 2019;457:168\u201379. https:\/\/doi.org\/10.1016\/j.canlet.2019.05.003.","journal-title":"Cancer Lett"},{"issue":"3","key":"5103_CR50","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/vco.12383","volume":"16","author":"K Sakai","year":"2018","unstructured":"Sakai K, Maeda S, Yamada Y, Chambers JK, Uchida K, Nakayama H, et al. Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours. Vet Comp Oncol. 2018;16(3):330\u20136. https:\/\/doi.org\/10.1111\/vco.12383.","journal-title":"Vet Comp Oncol"},{"key":"5103_CR51","doi-asserted-by":"publisher","first-page":"e36715","DOI":"10.1097\/MD.0000000000036715","volume":"102","author":"Y Fang","year":"2023","unstructured":"Fang Y, Yang W, Wu L, Yao L, Cao X, Chen H. An aging-related gene signature to predict the prognosis of hepatocellular carcinoma. Med (Baltim). 2023;102:e36715. https:\/\/doi.org\/10.1097\/MD.0000000000036715.","journal-title":"Med (Baltim)"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-05103-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05103-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:10:13Z","timestamp":1762884613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-05103-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5103"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-05103-1","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for HCC sample collection in this study was obtained from all clients at the first examination of their dogs. The normal liver was a piece of liver tissue that had been collected and cryopreserved in another project that was conducted according to the Guidelines of Animal Care and Use at Osaka Metropolitan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for the publication of HCC cases in this study was obtained from all patients during the first examination of their dogs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"654"}}